Evaluation of copeptin research on type 2 diabetic kidney function

A new predictive factor of early diabetic nephropathy--copeptin

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-14004237

Enrollment

Unknown

Registered

2014-02-06

Start date

2014-01-21

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic nephropathy

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

14 Years to 90 Years

Inclusion criteria

Inclusion criteria: Aged 14-90 years old; According to the world health organization (who) diagnosis of diabetes mellitus type 2 diabetes.

Exclusion criteria

Exclusion criteria: Type 1 diabetes; Secondary diabetes; Rule out has a history of autoimmune disease, hepatitis, cerebrovascular insufficiency, uremia, and urinary tract infection in patients with pregnancy; With diabetic ketoacidosis excluded, diabetic ketosis hypertonic coma acute complications such as diabetes; Other history of chronic kidney disease; Communication behavior disorder

Design outcomes

Primary

Measure	Time frame
copeptin;	—

Countries

China

Contacts

Public ContactHu Wen

Huai'an Second People's Hospital

huwen787878@163.com+86 15189658236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026